Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Sola International

This article was originally published in The Gray Sheet

Executive Summary

Sola International: Plans to submit registration statement to SEC for an offering of 2.8 mil. shares, including 2 mil. offered by the company and roughly 800,000 by selling shareholders. Proceeds from the offering, to be underwritten by Morgan Stanley and Merrill Lynch, will be used to repay debt expected to be incurred to finance Sola's recently announced acquisition of American Optical Corporation's ophthalmic eyeglass lens division ("The Gray Sheet" March 18, I&W-16)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel